Entera Health, LLC.

Industry

  • Pharmaceuticals
    • Nutraceuticals
  • Biotechnology
    • Large Molecule
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
See more in Biomedtracker

Latest on Entera Health, LLC.

Scrip

Tackling Acute Gastroenteritis: RedHill Biopharma's Bekinda A Novel Approach?

 
• By John Davis

The development of a long-acting ondansetron formulation, RedHill Biopharma Ltd. ’s Bekinda 24 mg once-daily extended-release tablets, for gastroenteritis, could change the way healthcare profess

Scrip

Deal Watch: United Therapeutics Looks To Extend PAH Dominance With Respira's Combo Product

 
• By Joseph Haas, Ian Haydock, Lubna Ahmed, and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions that occurred from March 30-April 1

In Vivo

Deals Shaping The Medical Industry, May 2017

 
• By Beth Allan, Deanna Kamienski, Maureen Riordan, Amanda Micklus, and Steven Muntner

IN VITRO DIAGNOSTICS Financings Quotient Ltd. Quotient Ltd. netted $45.4mm through a public sale of 8mm ordinary shares (including the overallotment) at $6. Funds will support ongoing scale-up and